The LIGHT–HVEM/LTβR axis is central to Crohn’s-like IBD pathogenesis. Upregulated LIGHT in active Crohn’s suggests it as a biomarker and therapeutic target. This evidence concerns the gene TNFSF14 and inflammatory bowel disease.